Protagonist Therapeutics (PTGX) EPS (2016 - 2026)
Protagonist Therapeutics (PTGX) EPS from Sep 30, 2016 to Mar 31, 2026. The TTM Protagonist Therapeutics (PTGX) EPS is -$1.84. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Protagonist Therapeutics (PTGX) EPS CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | -13.33% |
| 5 Years TTM | +1.43% |
| All Time TTM | -4.33% |
Annual EPS change of Protagonist Therapeutics (PTGX)
| Year | EPS | Change |
|---|---|---|
| 2026 | $0.06 | -102.83% |
| 2025 | -$2.08 | -146.13% |
| 2024 | $4.51 | -429.57% |
| 2023 | -$1.37 | -47.01% |
| 2022 | -$2.58 | -1.62% |
| 2021 | -$2.62 | +73.56% |
| 2020 | -$1.51 | -46.68% |
| 2019 | -$2.84 | +68.96% |
| 2018 | -$1.68 | -4.23% |
| 2017 | -$1.75 | -21.17% |
| 2016 | -$2.22 | N/A |
Comparison Protagonist Therapeutics (PTGX) five years EPS CAGR with competitors
Protagonist Therapeutics (PTGX) five years EPS CAGR is 1.43%.